Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis for prostaglandin and drug transport via SLCO2A1. | Nat Commun | 2026 | 41862483 | PubTator, text mining | PubMed |
| Influence of transporter polymorphisms on digoxin serum concentrations: a systematic review and meta-analysis. | Pharmacogenomics | 2026 | 41811250 | PubTator, text mining | PubMed |
| The role of ABC transporters in the human lung epithelium-insights from and limitations of current in vitro cell models. | In Vitro Model | 2026 | 41788234 | PubTator, text mining | PubMed |
| Purification and pharmacokinetic study of gadoxetate isomers for enhanced rabbit liver MR imaging. | PLoS One | 2026 | 41785220 | PubTator, text mining | PubMed |
| Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer. | Signal Transduct Target Ther | 2026 | 41781386 | PubTator, text mining | PubMed |
Computational identification of rare pathogenic genomic variants in esophageal cancer markers: Transcript-level analysis, sequence-based insights, and structural-functional impacts of non-synonymous SNPs. | Biochem Biophys Rep | 2026 | 41777455 | PubTator, text mining | PubMed |
| The value of gadobenate dimeglumine-enhanced MRI quantification in predicting aggressiveness and prognosis of typical intrahepatic mass-forming cholangiocarcinoma: a multicenter retrospective study. | Insights Imaging | 2026 | 41774304 | PubTator, text mining | PubMed |
| Regional absorption of talinolol mediated by intestinal transporters: insights from PBPK modeling analysis. | Front Pharmacol | 2026 | 41756241 | PubTator, text mining | PubMed |
| Recent Advances in Nanoparticle-Based Drug Delivery Strategies to Cross the Blood-Brain Barrier in Targeted Treatment of Alzheimer's Disease. | Pharmaceutics | 2026 | 41754934 | PubTator, text mining | PubMed |
| Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer. | Pharmaceuticals (Basel) | 2026 | 41754792 | PubTator, text mining | PubMed |
| HLA DRB1*01 and *04 Predisposition to Rheumatoid Arthritis and Polymorphisms of the SLCO1B1, MTHFR and PNPLA3 Genes Are Not Associated with Fatty Liver and Hepatotoxicity. | J Clin Med | 2026 | 41753255 | PubTator, text mining | PubMed |
| Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer. | Genes (Basel) | 2026 | 41751568 | PubTator, text mining | PubMed |
| A pH-Sensitive Sprayable Fluorescent Probe Enables Accurate Visualization of Thyroid Cancer Margins for Fluorescence-Guided Surgery in Orthotopic Mouse Models. | Cancers (Basel) | 2026 | 41749885 | PubTator, text mining | PubMed |
| Biotransformation Is an Effective Mechanism for Modulating the Biological Toxicity of Nodularin (NODR). | Toxins (Basel) | 2026 | 41745757 | PubTator, text mining | PubMed |
| Indoxyl Sulfate in the Gut-Kidney Axis: Pathophysiology and Clinical Significance in CKD-Associated Colorectal Cancer. | Toxins (Basel) | 2026 | 41745738 | PubTator, text mining | PubMed |
| Constitutional indocyanine green excretion defect in a Chinese patient without underlying liver disease: case report and mechanistic insights. | Front Med (Lausanne) | 2026 | 41737405 | PubTator, text mining | PubMed |
| Hepatitis C Management in a Lung Cancer Patient on Checkpoint Inhibition: A Case Report. | Cureus | 2026 | 41737076 | PubTator, text mining | PubMed |
| Risk Assessment for Drug-Induced Hyperbilirubinemia: A Mechanistic Approach. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41734150 | PubTator, text mining | PubMed |
| Genetic modifiers of APOE-ε4-associated cognitive decline. | Nat Commun | 2026 | 41720779 | PubTator, text mining | PubMed |
| Response to Tutorial Drug-Drug Interactions by EM Sellers. | Clin Transl Sci | 2026 | 41720634 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=2